LONDON MARKET CLOSE: FTSE 100 up as US jobs data eases rate hike fears
(Alliance News) - European stocks soared on Thursday as weaker than expected US jobs figures dampened market worries of a near-term interest rate hike across the pond. Read More
| Price | 1,994.50p on 03-07-2026 at 11:21:02 |
|---|---|
| Change | -9.50p -0.47% |
| Buy | 1,994.50p |
| Sell | 1,993.50p |
| Last Trade: | Buy 28.00 at 1,994.50p |
| Day's Volume: | 963,301 |
| Last Close: | 2,004.00p |
| Open: | 2,005.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 1,988.00p - 2,013.00p |
| 52wk Range: | 1,315.00p - 2,282.00p |
| Market Capitalisation: | £79.89b |
| VWAP: | 1,999.62469p |
| Shares in Issue: | 4.01b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 28 | 1,994.50p | Automatic Execution |
12:20:55 - 03-Jul-26 |
| Buy* | 9 | 1,994.50p | SI Trade |
12:20:55 - 03-Jul-26 |
| Buy* | 15 | 1,994.426p | Ordinary |
12:20:50 - 03-Jul-26 |
| Buy* | 4 | 1,994.50p | SI Trade |
12:20:47 - 03-Jul-26 |
| Buy* | 997 | 1,994.049p | Ordinary |
12:20:39 - 03-Jul-26 |
| Buy* | 80 | 1,994.275p | Ordinary |
12:20:32 - 03-Jul-26 |
| Sell* | 7 | 1,993.50p | Automatic Execution |
12:20:28 - 03-Jul-26 |
| Sell* | 153 | 1,993.50p | SI Trade |
12:20:27 - 03-Jul-26 |
| Sell* | 182 | 1,993.25p | SI Trade |
12:20:21 - 03-Jul-26 |
| Buy* | 236 | 1,993.50p | Automatic Execution |
12:20:21 - 03-Jul-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Jul 2026 3:00 pm | RNS | Total Voting Rights |
| 29th Jun 2026 3:00 pm | RNS | Transaction in Own Shares |
| 29th Jun 2026 3:00 pm | RNS | Holding(s) in Company |
| 26th Jun 2026 3:00 pm | RNS | Holding(s) in Company |
| 24th Jun 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 24th Jun 2026 2:52 pm | RNS | GSK announces tender offer to acquire Nuvalent |
| 23rd Jun 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 22nd Jun 2026 3:00 pm | RNS | Transaction in Own Shares |
| 17th Jun 2026 4:06 pm | RNS | cUTI oral antibiotic Tebipenem approved by US FDA |
| 15th Jun 2026 3:00 pm | RNS | Transaction in Own Shares |